# marketRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/marketrx

- Industry: Healthcare IT
- Headquarters: Bridgewater, US
- Website: www.marketrx.com
- Total disclosed funding: $10M
- Latest round: Series C (Oct 8, 2003)
- Investors on record: 2

## About

MarketRx Inc. specializes in providing analytical solutions tailored for the healthcare sector, primarily focusing on the pharmaceutical industry. Their advanced tools equip businesses with crucial market insights and data-driven strategies.MarketRx Inc. operates in the healthcare analytics space, offering data solutions specifically designed for pharmaceutical companies. The company was acquired by Cognizant Technology Solutions Corporation in November 2007 for USD 135 mn. The firm is headquartered in Bridgewater, US, and has undergone significant transformation through its acquisition. There are no known subsidiaries or pivots in business strategy. Limited information is available regarding the founder's history or previous ventures.MarketRx.com provides a suite of analytical solutions designed to empower businesses within the healthcare sector, focusing primarily on the pharmaceutical industry. Their core offerings include advanced data analytics platforms that facilitate market research, sales forecasting, and competitive intelligence. These tools are engineered to help clients make informed decisions by providing insights into market trends, customer behavior, and product performance. The end users primarily consist of pharmaceutical companies, healthcare providers, and market researchers who leverage these services to optimize their marketing strategies and enhance operational efficiencies. MarketRx.com has established a presence in various geographical markets, notably serving clients in North America, Europe, and Asia, thereby enabling a wide range of organizations to refine their market approaches and improve patient outcomes.MarketRx.com generates revenue through a combination of subscription-based models and tailored service agreements with its clients. Transactions typically involve clients entering into multi-year agreements that include access to their suite of analytics tools and ongoing consultancy to interpret the data provided. Clients may subscribe to different tiers of service depending on their specific needs, which may include enhanced reporting capabilities and specialized market insights. The pricing structure is designed to accommodate varying levels of engagement, allowing organizations to choose plans that align with their operational requirements. Flagship services encompass proprietary analytics products that directly address the needs of the pharmaceutical industry, ensuring that clients receive high-value insights for their investment.Following its acquisition by Cognizant Technology Solutions in November 2007, MarketRx Inc. aims to leverage its robust analytics capabilities to launch new products targeting specific healthcare needs. The firm is also strategically planning to expand its services into new geographic markets, with a focus on regions in Europe and Asia by the end of 2025. Recent funding from the acquisition is expected to bolster these initiatives, primarily through the enhancement of their product offerings and market penetration efforts.

## Funding rounds

- Series C, Oct 8, 2003, $10M — WestBridge Capital Partners, Andwel Partners

## Investors

- WestBridge Capital Partners (https://capitalatlas.ai/funds/westbridge-capital-partners) — Series C
- Andwel Partners — Series C